OrganiGram
Organigram Global is Canada's #1 cannabis producer, manufacturing flower, vapes, edibles, and beverages across five facilities. It sells recreational and medical cannabis under brands including SHRED, BOXHOT, and Edison in Canada, Germany, Australia, the UK, and the US.
- Company typePublic
- Founded2013
- HeadquartersMoncton, Canada
- Headcount501–1,000
- GTM typeB2C
- OfferingHardware or Manufacturing
What OrganiGram does
Organigram Global Inc. (TSX/NASDAQ: OGI) is Canada's largest cannabis producer by recreational net revenue, operating five purpose-built facilities across Canada (Moncton, Winnipeg, Aylmer, London, and Lac-Supérieur) with a combined annual production capacity exceeding 20,000 kg. Founded in 2013 as a medical cannabis provider and rebranded to Organigram Global in 2024, the company manufactures flower, pre-rolls, vapes, edibles (up to 4M gummies/month at Winnipeg), concentrates (up to 1,200 kg distillate/month at Aylmer), and beverages under a portfolio of brands including SHRED (milled flower, pre-rolls, gummies, hash), BOXHOT (vapes with 20%+ Canadian category share), Edison (premium innovation including JOLTS lozenges and FAST™ nanoemulsion gummies), Big Bag o' Buds (value), Trailblazer, DEBUNK, Tremblant, Monjour, and Collective Project. The company's principal technology differentiator is its patent-pending FAST™ nanoemulsion platform, clinically validated to deliver ~50% faster onset and nearly double cannabinoid delivery versus traditional edibles, and applied across gummies, lozenges, and beverages.
Organigram generates revenue primarily through wholesale supply to Canadian provincial cannabis boards (Ontario Cannabis Store, BC Liquor Distribution Branch, SAQ, etc.) for recreational products, with additional revenue from medical cannabis sales in Canada, Germany, Australia, and the UK via pharmacy networks and telemedicine. The company pursues a multi-channel distribution model: direct sales to provincial boards and retailers in Canada, international export partnerships (Sanity Group in Germany with 2,000+ pharmacy reach, Leafio/Montu in Australia with 4,000+ pharmacies), and U.S. retail distribution of hemp-derived THC beverages and gummies via Total Wines and Top 10 Liquors. Customer segments span recreational consumers across price points (value to premium), medical patients in multiple jurisdictions, and international distributors seeking EU-GMP-certified supply. Most recently, Q2 FY2026 net revenue was $59.8M USD (down 9% YoY) with management targeting >C$300M for FY2026.
The company's strategic capital partner is British American Tobacco (BAT), which has invested over $345M CAD across three tranches (2021, 2023/24, 2026) to reach approximately 48.4% ownership. BAT funds the Jupiter Strategic Investment Pool earmarked for further U.S./international M&A and supports a Centre of Excellence for next-generation cannabis product R&D at Moncton. In December 2024 Organigram acquired Motif Labs to achieve #1 Canadian market position; in April 2025 it acquired Collective Project to enter the U.S. hemp-derived THC beverage category; and in April 2026 it completed the acquisition of Sanity Group GmbH for €107.3M upfront plus up to €113.8M in earnout, establishing a leading position in the German federally legal cannabis market. The company is led by CEO James Yamanaka (effective January 2026), formerly Global Head of Strategy at BAT.
OrganiGram firmographics
Firmographics- Name
- OrganiGram
- Legal name
- Organigram Inc.
- Website
- https://organigram.ca
- Company type
- Public
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Organigram Global is Canada's #1 cannabis producer, manufacturing flower, vapes, edibles, and beverages across five facilities. It sells recreational and medical cannabis under brands including SHRED, BOXHOT, and Edison in Canada, Germany, Australia, the UK, and the US.
- Ownership category
- akta.pro rank
OrganiGram industry classification
Industry- Product category
- Cannabis Products
- NAICS
- Medicinal and Botanical Manufacturing (325411), Beverage Manufacturing (3121)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH)
- akta.pro secondary industries
- Herbal & Botanical Supplements (CRADAGAD), Botanical/Herbal & Adaptogen Functional Beverage Production (AFAFAFAF)
Keywords
Where OrganiGram is headquartered
LocationHeadquarters
- HQ city
- Moncton
- HQ country
- Canada
- HQ region
- North America
Offices6 records
Markets served
OrganiGram business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Recreational Cannabis Sales: Sale of recreational cannabis products through Canadian provincial boards and retailers. Products include flower, pre-rolls, vapes, edibles, and concentrates across multiple brand portfolios. Revenue subject to Canadian excise duties.
- Medical Cannabis Sales: Sale of medical cannabis products to patients in Canada and international markets including Germany, Australia, and UK through pharmacies and telemedicine platforms.
- U.S. Hemp-Derived THC Beverages: Sale of hemp-derived THC beverages through Collective Project brand in U.S. states where permitted, reaching consumers via Total Wines, Top 10 Liquors, and other retailers.
- International Export: Export of cannabis flower and products to international markets. International shipments are not subject to Canadian excise duties, providing higher margin potential upon EU-GMP certification.
Go-to-market motion4 records
Distribution channels6 records
Marketing channels6 records
OrganiGram product offering
Product offeringCore offering
Organigram Global is a Canadian licensed producer that cultivates, manufactures, and distributes medical and recreational cannabis products, including dried flower, pre-rolls, vapes, edibles, and beverages, across a portfolio of consumer brands. The company operates five purpose-built production facilities in Canada and distributes through Canadian provincial boards, international pharmacy networks, and U.S. retail channels for hemp-derived THC beverages.
Product overview
OrganiGram operates a diversified cannabis product portfolio spanning multiple categories including flower, concentrates, vapes, edibles, and beverages. The company holds the #1 market position in Canada across several categories. Core brands include SHRED (mainstream, $224M annual retail sales), BOXHOT (leading vape brand, $150M annualized sales), and Edison (premium innovation). The company pioneered FAST™ patent-pending nanoemulsion technology enabling faster-onset edibles and beverages. Brands range from value-oriented (Big Bag o' Buds) to premium (Edison, Trailblazer), serving both recreational and wellness consumers. International expansion includes hemp-derived THC products (happly, Collective Project) in the US market.
Differentiator
Problem solved
Functional benefit
Brands
- SHRED: Award-winning mainstream brand with $224 million in annual retail sales; leads in milled flower, pre-rolls, gummies, and Rip Strip Hash
- BOXHOT
- Edison
- Big Bag o' Buds
- DEBUNK
- Rizzlers
- Trailblazer
- Monjour
- Tremblant
- Collective Project
- Happly
- Fetch
- Wola
Products and services
- SHRED Mainstream cannabis brand offering pre-milled flower, gummies, hash strips, and infused pre-rolls for adult recreational consumers.
- BOXHOT Leading high-potency cannabis vape brand with portfolio of vapes, infused pre-rolls, and distillate products for recreational consumers.
- Edison Premium cannabis brand featuring innovative product formats such as ingestible lozenges and FAST™ nanoemulsion edibles for premium experience seekers.
- Edison Sonics Gummies FAST™ nanoemulsion cannabis gummies with clinically proven faster onset and higher bioavailability than traditional edibles.
- SHRED Shotz Cannabis-infused nanoemulsion shot beverage with 10mg THC per 65ml serving, designed for faster onset versus traditional edibles.
- Big Bag o' Buds Value-priced cannabis brand offering whole-flower cannabis in various sizes and pre-rolls for budget-conscious recreational consumers.
- DEBUNK Premium high-potency cannabis vapes, concentrates, and infused pre-rolls targeting experienced consumers seeking bold flavors.
- Rizzlers Cannabis vape products with flavor-focused high-potency inputs paired with user-friendly hardware.
- Trailblazer High-THC cannabis flower and pre-rolls, hang-dried, hand-packed, and sealed in glass jars for premium consumers.
- Monjour CBD-forward cannabis edibles infused with minor cannabinoids such as CBG and CBN, formulated as vegan-friendly wellness products.
- Tremblant Premium hash products using traditional craftsmanship techniques, including hand-rolled hash balls and pressed varieties.
- Collective Project Flavor-forward cannabis and hemp-derived THC beverage brand available in Canadian and U.S. retail channels.
- Fetch Accessibly priced cannabis beverages in nostalgic flavors, offered in regular and zero-sugar options.
- happly Hemp-derived THC gummies with mood-state-targeted formulations (Socialize, Relax, Sleep) using FAST™ nanoemulsion technology for the U.S. market.
- Wola Quebec-focused cannabis brand featuring locally grown flower, smooth-burning pre-rolls, and traditional hash.
- Rip-Strips Hash Tear-off hash strips allowing portion-controlled use, sold under the SHRED brand.
- Edison and BOXHOT Medical Cannabis Vapes and Pastilles (Australia) Medical cannabis vape and pastille product range launched in Australia via Leafio distribution covering over 4,000 pharmacies.
Quantifiable outcome
- ~50% faster onset compared to traditional edibles with nearly double cannabinoid delivery at peak effect
- +4 more outcomes
Companies that use OrganiGram
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
OrganiGram technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
OrganiGram partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Leafio (Montu Australia)coreDistribution partnership for 10 Edison and BOXHOT medical cannabis vape and pastille SKUs across 4,000+ Australian pharmacies via Leafio's nationwide supply chain.
- Phylos Biosciencecore$10 million investment providing priority access to autoflower genetics pipeline including 30 new genetics delivered twice annually through 2030. Five-year exclusive rights for selected genetics in Canada, Australia, UK, Germany, and Israel. Advancing seed-based cultivation strategy.
- Collective ProjectcoreAcquisition of U.S. hemp-derived THC beverage company enabling entry into U.S. market. Products available in 10+ states including Total Wines and Top 10 Liquors. Brand leverages Collective Arts cultural positioning.
- Motif LabscoreAcquired December 2024 for undisclosed amount, Motif Labs acquisition propelled Organigram to #1 market position in Canada. Added extraction facility, logistics hub, vape and pre-roll production capabilities, and identified $10 million in annual cost synergies.
- Sanity GroupcoreOrganigram acquired Sanity Group in April 2026 for €107.3 million upfront plus earnout. Sanity Group operates Germany's largest medical cannabis distribution network with 2,000+ pharmacy relationships and telemedicine platform. Provides Organigram access to rapidly growing European market.
Scale indicators19 records
Recent moves10 records
Expansion highlights7 records
OrganiGram competitors and assessment
Company assessmentDirect peers
- Tilray Brands: Largest Canadian licensed producer with a diversified cannabis portfolio spanning flower, vapes, edibles, beverages, and wellness. Tilray is Organigram's most direct competitor in the Canadian recreational market and similarly pursuing international and U.S. beverage expansion.
- Canopy Growth: Major Canadian licensed producer with broad recreational and medical cannabis offerings, including Tweed and Spectrum Cannabis brands. Competes directly with Organigram across Canadian provincial board channels and is pursuing global medical cannabis expansion.
- Aurora Cannabis: Canadian licensed producer focused on medical cannabis globally and recreational in Canada. Comparable to Organigram in vertical integration and international medical distribution strategy.
- Cronos Group: Canadian licensed producer with strategic backing from Altria. Closely comparable to Organigram in pairing a tobacco-industry strategic shareholder with multi-country cannabis operations and product innovation focus.
- Trulieve Cannabis: U.S. multi-state operator with vertically integrated cultivation, extraction, and retail. Comparable to Organigram in scale-driven, multi-state strategy, though focused on U.S. state-legal medical and adult-use markets.
- Curaleaf Holdings: U.S. multi-state cannabis operator with broad product portfolio across flower, vapes, edibles, and beverages. Comparable to Organigram's diversified product mix and international expansion ambitions.
- Green Thumb Industries: U.S. cannabis operator with national brand portfolio across multiple states. Similar vertical integration and brand-led growth model to Organigram's SHRED, BOXHOT, and Edison portfolio.
- SNDL Inc. Canadian licensed producer with retail and cultivation assets, competing across recreational flower and value-priced formats. Comparable to Organigram's mainstream positioning through Big Bag o' Buds and SHRED.
- Village Farms International: Canadian greenhouse operator with cannabis division producing dried flower, pre-rolls, and edibles. Comparable to Organigram in leveraging large-scale greenhouse and indoor cultivation for cannabis production.
Broad incumbents
- High Tide: Canadian cannabis retailer with proprietary e-commerce platform and accessories business. Adjacent to Organigram's wholesale and brand portfolio through its retail distribution focus and CPG-style accessory merchandising.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
OrganiGram social profiles
Digital presenceOrganiGram financial estimates
Financial estimateRevenue estimate
Valuation estimate
OrganiGram leadership team
Management profileNumber of profiles
Profiles12 records
OrganiGram subsidiaries and ownership
Company hierarchySubsidiaries7 records
OrganiGram funding detail
Funding detailFunding overview
Funding rounds14 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OrganiGram M&A and investment
M&A and investmentM&A5 records
Investments11 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OrganiGram
What does OrganiGram do?
Organigram Global is a Canadian licensed producer that cultivates, manufactures, and distributes medical and recreational cannabis products, including dried flower, pre-rolls, vapes, edibles, and beverages, across a portfolio of consumer brands. The company operates five purpose-built production facilities in Canada and distributes through Canadian provincial boards, international pharmacy networks, and U.S. retail channels for hemp-derived THC beverages.
Is OrganiGram a public or private company?
OrganiGram is a public company. It is classified as public and is currently operating.
When was OrganiGram founded?
OrganiGram was founded in 2013. It employs 501 to 1,000 people.
Where is OrganiGram based?
OrganiGram is headquartered in Moncton, Canada, in the North America region.
How does OrganiGram make money?
Four revenue lines are on record. Recreational Cannabis Sales are the primary driver. The others are medical Cannabis Sales, U.S. Hemp-Derived THC Beverages and international Export.
Who are OrganiGram's main competitors?
Direct peers on record are Tilray Brands, Canopy Growth, Aurora Cannabis, Cronos Group, Trulieve Cannabis, Curaleaf Holdings, Green Thumb Industries, SNDL Inc. and Village Farms International. High Tide is listed as a broad incumbent.
Does OrganiGram have an API?
No public API is recorded for OrganiGram.
What industry is OrganiGram in?
OrganiGram's product category is Cannabis Products. Its primary akta.pro industry code is CRANAFAH, Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise), with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2833.